Maximum resection and immunotherapy improve glioblastoma patient survival: a retrospective single-institution prognostic analysis

Glioblastoma (GBM) is a refractory disease with a poor prognosis and various methods, including maximum resection and immunotherapy, have been tested to improve outcomes. In this retrospective study we analyzed the prognostic factors of 277 newly diagnosed GBM patients over 11 years of consecutive c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Neurol
Main Authors: Ishikawa, Eiichi, Sugii, Narushi, Matsuda, Masahide, Kohzuki, Hidehiro, Tsurubuchi, Takao, Akutsu, Hiroyoshi, Takano, Shingo, Mizumoto, Masashi, Sakurai, Hideyuki, Matsumura, Akira
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8287820/
https://ncbi.nlm.nih.gov/pubmed/34281518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-021-02318-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados